RESMED INC

NYSE: RMD (ResMed Inc.)

Kemas kini terakhir: 18 jam lalu

237.85

-0.34 (-0.14%)

Penutupan Terdahulu 238.19
Jumlah Dagangan 1,454,603
Harga / Pendapatan (P/E Ke hadapan) 19.83
Harga / Jualan (P/S) 6.07
Harga / Buku (P/B) 5.66
Julat 52 Minggu
180.27 (-24%) — 277.67 (16%)
Hasil Dividen (DY TTM) 1.08%
Margin Keuntungan 26.15%
Margin Operasi (TTM) 33.00%
EPS Cair (TTM) 8.92
Pertumbuhan Hasil Suku Tahunan (YOY) 7.90%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 21.50%
Jumlah Hutang/Ekuiti (D/E MRQ) 15.14%
Nisbah Semasa (MRQ) 3.41
Aliran Tunai Operasi (OCF TTM) 1.65 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 1.20 B
Pulangan Atas Aset (ROA TTM) 14.01%
Pulangan Atas Ekuiti (ROE TTM) 25.81%

AISkor Stockmoo

0.2
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Harga tinggi berbanding pertumbuhan perolehannya. info
Harga menyiratkan pertumbuhan perolehan 18.5% setahun; perniagaan boleh membiayai kira-kira 15.0% setahun. info
Lebih murah daripada penilaian biasanya. info
Hutang rendah. Keuntungan kukuh. Kecairan jangka pendek mencukupi. Aliran tunai positif. info
Pulangan jauh melebihi kos modalnya. Pulangan atas modal meningkat. info
Daripada analisis teknikal AI kami terhadap carta. info NA
Tiada aliran jelas sepanjang tahun lalu. Agak di bawah paras tertinggi 52 minggu. info
Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga hampir dengan purata itu. Kenaikan terkini melepasi rintangan belum disahkan. info
Corak Lilin info NA
Di atas garis aliran jangka sederhana. info
Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info
Berita terkini bercampur atau neutral. info
Beberapa orang dalam menjual bersih baru-baru ini. Harga di atas harga jualan orang dalam. info
Institusi bersih -4.56% daripada saham dalam pemfailan 13F terkini: 414 pemegang menambah, 481 mengurang (suku berakhir 30 Sep 2026). info
Persekitaran pasaran berhati-hati. info
Sektor mengatasi prestasi pasaran.
Tonggak-tonggak tidak sependapat, jadi skor dilemahkan.
Harga tinggi berbanding purata 52 minggunya. info
Momentum jangka pendek semakin lemah. info
Harga di antara sokongan dan rintangan. info
Skor Akhir 0.22
Tunjuk semua

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Bercampur
Medical Instruments & Supplies (Global) Bercampur Bercampur
Stok ResMed Inc. Bercampur Menurun

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
RMD - 1.08% - 5.66
BDX - 2.20% - 2.41
WST - 0.37% - 9.67
BLCO - - - 1.17
ALC - 0.49% - 1.64
STVN - 0.30% - 2.39

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Mid Core
% Dimiliki oleh Orang Dalam 0.78%
% Dimiliki oleh Institusi 65.16%

Tiada data dalam julat masa ini.

Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
BLOOMER AARON - 238.53 -1,095 -261,190
DE WITTE JAN - 238.53 -60 -14,312
FARRELL MICHAEL J. - 237.47 -13,104 -3,111,767
FARRELL PETER C - 238.53 -169 -40,312
GILL HARJIT - 238.53 -36 -8,587
RIDER MICHAEL J - 238.53 -1,944 -463,702
Jumlah Keseluruhan Kuantiti Bersih -16,408
Jumlah Keseluruhan Nilai Bersih ($) -3,899,870
Purata Pembelian Keseluruhan ($) -
Purata Jualan Keseluruhan ($) 237.68
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
RIDER MICHAEL J Pegawai 11 Nov 2026 Dibuang (-) 1,944 238.53 463,702
GILL HARJIT Pengarah 11 Nov 2026 Dibuang (-) 36 238.53 8,587
DE WITTE JAN Pengarah 11 Nov 2026 Dibuang (-) 60 238.53 14,312
FARRELL PETER C Pengarah 11 Nov 2026 Dibuang (-) 169 238.53 40,312
BLOOMER AARON Pegawai 11 Nov 2026 Dibuang (-) 1,095 238.53 261,190
FARRELL MICHAEL J. Pegawai 11 Nov 2026 Dibuang (-) 8,111 238.53 1,934,717
FARRELL MICHAEL J. Pegawai 09 Nov 2026 Jual automatik (-) 4,993 235.74 1,177,050
FARRELL MICHAEL J. Pegawai 09 Nov 2026 Pelaksanaan pilihan 4,993 - -

Institusi

Pemilikan institusi: 80.42%

Kedudukan Pemegang Saham
Bertambah 414 4,315,361
Berkurang 481 10,303,418
Baharu 115 481,103
Dijual habis 117 920,995

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

2 Positif 1 Negatif 0 Neutral
Tarikh Jenis Butiran
06 Nov 2026 Yahoo Finance Don’t Lose Sleep Over GLP-1s: Why ResMed Stock Is a Bargain
ResMed, whose devices treat sleep apnea, has dropped on unfounded concerns that weight-loss drugs will replace its treatment. The stock is cheap and worth buying at current prices.
02 Nov 2026 Yahoo Finance ResMed: 3 Key Takeaways for Long-Term Investors
Manufacturing gains are lifting margins faster than revenue growth, signaling operational leverage ahead.
01 Nov 2026 Yahoo Finance What Sent ResMed Stock Lower?
For questions about this article or underlying research, email [email protected].
31 Oct 2026 Yahoo Finance RMD Q3 deep dive: product innovation and supply chain execution drive results amid evolving landscape
Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q1 2027), with sales up 5.9% year on year to $1.41 billion. Its non-GAAP profit of $2.91 per share was 8.9% above analysts’ consensus estimates.
30 Oct 2026 Yahoo Finance ResMed (RMD) Looks Fully Valued After Another Earnings Beat
ResMed (RMD) just posted quarterly results that topped analyst expectations on both earnings and revenue, while reaffirming its full year outlook and highlighting firm demand for sleep devices, masks, and digital health tools. ResMed’s share price has climbed 13.5% over the past month and 19.8%…
30 Oct 2026 Yahoo Finance ResMed (RMD) Q1 2027 Earnings Call Transcript
Sleep device revenue grew 6% as AI tools boost therapy compliance and partnerships expand.
30 Oct 2026 Yahoo Finance ResMed (RMD) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
30 Oct 2026 Yahoo Finance ResMed Inc. Q1 2027 Earnings Call Summary
Moby summary of ResMed Inc.'s Q1 2027 earnings call…
30 Oct 2026 Yahoo Finance What ResMed (RMD) Said on Its Q1 Earnings Call
ResMed (NYSE:RMD) reported first-quarter fiscal 2027 revenue of $1.4 billion, up 6% from a year earlier on a reported basis and 7% on a core constant-currency basis, as growth in sleep devices, masks and residential care software offset declines in life-support device sales. Non-GAAP diluted earning…
30 Oct 2026 Yahoo Finance RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs
ResMed's first-quarter fiscal 2027 earnings and revenues top estimates as sustained sleep device demand, productivity gains and gross margin expansion drive growth.
29 Oct 2026 Yahoo Finance ResMed (NYSE:RMD) posts better-than-expected sales in Q3 CY2026
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q1 2027), with revenue rising 5.9% year on year to $1.41 billion. Its non-GAAP profit of $2.91 per share was 8.9% above analysts’ consensus estimates.
29 Oct 2026 Yahoo Finance ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
ResMed (RMD) delivered earnings and revenue surprises of +8.99% and +1.66%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
29 Oct 2026 Yahoo Finance ResMed: Fiscal Q1 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal first-quarter net income of $418…
29 Oct 2026 Yahoo Finance Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basisQ1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91Returned more than $1.0 billion to shareholders through share repurchases and dividends during Q1 Note: A webcast of Resmed’s…
29 Oct 2026 Yahoo Finance Ozlo Raises $22 Million Series B Led by Modi Ventures to Expand Its Sleep Technology Ecosystem
Funding will accelerate product development, sleep research, and new technologies addressing a broader range of sleep and nighttime health needs BOSTON, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Ozlo, the sleep technology company behind Ozlo Sleepbuds®, announced it has raised $22 million in Series B…
28 Oct 2026 Yahoo Finance Unlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for ResMed (RMD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026…
Papar semua
Hasil Dividen (DY TTM) 1.08%
Purata Hasil Dividen 5T 0.72%
Nisbah Pembayaran 23.23%
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
13 Feb 2025 30 Jan 2025 20 Mar 2025 0.53 Tunai
07 Nov 2024 24 Oct 2024 12 Dec 2024 0.53 Tunai
15 Aug 2024 01 Aug 2024 19 Sep 2024 0.53 Tunai
08 May 2024 25 Apr 2024 13 Jun 2024 0.48 Tunai
07 Feb 2024 24 Jan 2024 14 Mar 2024 0.48 Tunai
08 Nov 2023 26 Oct 2023 14 Dec 2023 0.48 Tunai
16 Aug 2023 03 Aug 2023 21 Sep 2023 0.48 Tunai
10 May 2023 27 Apr 2023 15 Jun 2023 0.44 Tunai
08 Feb 2023 26 Jan 2023 16 Mar 2023 0.44 Tunai
09 Nov 2022 27 Oct 2022 15 Dec 2022 0.44 Tunai
17 Aug 2022 11 Aug 2022 22 Sep 2022 0.44 Tunai
11 May 2022 28 Apr 2022 16 Jun 2022 0.42 Tunai
09 Feb 2022 27 Jan 2022 17 Mar 2022 0.42 Tunai
09 Nov 2021 28 Oct 2021 16 Dec 2021 0.42 Tunai
18 Aug 2021 05 Aug 2021 23 Sep 2021 0.42 Tunai
12 May 2021 29 Apr 2021 17 Jun 2021 0.39 Tunai
10 Feb 2021 28 Jan 2021 18 Mar 2021 0.39 Tunai
10 Nov 2020 29 Oct 2020 17 Dec 2020 0.39 Tunai
19 Aug 2020 05 Aug 2020 24 Sep 2020 0.39 Tunai
13 May 2020 30 Apr 2020 18 Jun 2020 0.39 Tunai
12 Feb 2020 30 Jan 2020 19 Mar 2020 0.39 Tunai
06 Nov 2019 25 Oct 2019 12 Dec 2019 0.39 Tunai
14 Aug 2019 26 Jul 2019 19 Sep 2019 0.39 Tunai
08 May 2019 03 May 2019 13 Jun 2019 0.37 Tunai
06 Feb 2019 25 Jan 2019 14 Mar 2019 0.37 Tunai
07 Nov 2018 26 Oct 2018 13 Dec 2018 0.37 Tunai
15 Aug 2018 03 Aug 2018 20 Sep 2018 0.37 Tunai
09 May 2018 26 Apr 2018 14 Jun 2018 0.35 Tunai
07 Feb 2018 23 Jan 2018 15 Mar 2018 0.35 Tunai
08 Nov 2017 26 Oct 2017 14 Dec 2017 0.35 Tunai
15 Aug 2017 01 Aug 2017 21 Sep 2017 0.35 Tunai
09 May 2017 27 Apr 2017 15 Jun 2017 0.33 Tunai
07 Feb 2017 23 Jan 2017 16 Mar 2017 0.33 Tunai
08 Nov 2016 25 Oct 2016 15 Dec 2016 0.33 Tunai
16 Aug 2016 28 Jul 2016 22 Sep 2016 0.33 Tunai
17 May 2016 26 Apr 2016 16 Jun 2016 0.3 Tunai
09 Feb 2016 21 Jan 2016 17 Mar 2016 0.3 Tunai
17 Nov 2015 22 Oct 2015 17 Dec 2015 0.3 Tunai
18 Aug 2015 30 Jul 2015 17 Sep 2015 0.3 Tunai
19 May 2015 23 Apr 2015 18 Jun 2015 0.28 Tunai
10 Feb 2015 22 Jan 2015 19 Mar 2015 0.28 Tunai
18 Nov 2014 23 Oct 2014 18 Dec 2014 0.28 Tunai
19 Aug 2014 31 Jul 2014 18 Sep 2014 0.28 Tunai
16 May 2014 23 Apr 2014 17 Jun 2014 0.25 Tunai
14 Feb 2014 23 Jan 2014 19 Mar 2014 0.25 Tunai
15 Nov 2013 24 Oct 2013 18 Dec 2013 0.25 Tunai
16 Aug 2013 01 Aug 2013 17 Sep 2013 0.25 Tunai
17 May 2013 25 Apr 2013 18 Jun 2013 0.17 Tunai
14 Feb 2013 24 Jan 2013 19 Mar 2013 0.17 Tunai
16 Nov 2012 25 Oct 2012 18 Dec 2012 0.17 Tunai
05 Sep 2012 02 Aug 2012 28 Sep 2012 0.17 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 0.530 1 0.22
2024 2.02 4 0.88
2023 1.84 4 1.07
2022 1.72 4 0.83
2021 1.62 4 0.62
2020 1.56 4 0.73
2019 1.52 4 0.98
2018 1.44 4 1.27
2017 1.36 4 1.61
2016 1.26 4 2.03
2015 1.16 4 2.16
2014 1.06 4 1.89
2013 0.840 4 1.78
2012 0.340 2 0.82
Papar semua

Isyarat Terkini corak lilin dan silang EMA

▲ Silang emas 18 sesi lalu · 22 Oct
Jangka panjang · EMA 50/200
EMA 50 hari melintas ke atas EMA 200 hari, tanda yang diperhatikan ramai bahawa arah aliran jangka panjang telah berubah menaik.

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan
Dagangan
Aliran menaik: harga di atas purata bergeraknya, dan purata itu sedang meningkat. Harga hampir dengan purata itu. Kenaikan terkini melepasi rintangan belum disahkan.
Sokongan terdekat: 226.75 – 237.30 · paras kukuh
Rintangan terdekat: 236.57 – 240.17 · paras lemah

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda